Skip to main content
Smart Investors Daily
ES

NASDAQ · ESLA

Estrella Immunopharma, Inc.

Healthcare · Biotechnology

$0.34

Up+$0.01 (+2.25%)

Updated Nov 20, 2026, 3:40 AM

SID Score

2.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
70.24M
P/E ratio
-5.57
Dividend yield
0.00%
52-week range
$0.24 – $2.27
Volume
223.92K
Avg. volume
283.2K

Price performance · ESLA

ESLA price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

ESLA closed at $0.34 after 21 trading sessions, down 53.16% for the selected period.

Last close
$0.34
Period change
-53.16%
Period low
$0.33
Period high
$0.99
Daily close
View OHLC price history
ESLA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$0.333$0.39$0.333$0.3404223.92K
Nov 18, 2026$0.335$0.38$0.33$0.3329446.88K
Nov 17, 2026$0.44$0.4699$0.30$0.3316747.76K
Nov 16, 2026$0.4986$0.5248$0.38$0.38532.63K
Nov 13, 2026$0.5208$0.5518$0.4638$0.514222.77K
Nov 12, 2026$0.799$0.799$0.40$0.51891.59M
Nov 11, 2026$0.7748$0.8506$0.7306$0.7939783.94K
Nov 10, 2026$0.53$0.7699$0.53$0.74723.95M
Nov 9, 2026$0.43$0.5988$0.43$0.51396.58M
Nov 6, 2026$0.40$0.4448$0.3716$0.3753140.93K
Nov 5, 2026$0.444$0.444$0.40$0.4101163.05K
Nov 4, 2026$0.438$0.48$0.4029$0.4435128.75K
Nov 3, 2026$0.429$0.475$0.3517$0.418526.47K
Nov 2, 2026$0.6393$0.6393$0.425$0.4263617.05K
Oct 30, 2026$0.72$0.7869$0.6243$0.6393165.73K
Oct 29, 2026$0.8118$0.825$0.7011$0.7287271.2K
Oct 28, 2026$0.9176$0.9899$0.7512$0.8217495.66K
Oct 27, 2026$0.8804$0.95$0.8456$0.9323614.63K
Oct 26, 2026$1.05$1.15$0.8801$0.91882.59M
Oct 23, 2026$0.764$0.999$0.7406$0.9853.72M
Oct 22, 2026$0.5615$0.7588$0.555$0.72686.85M

Latest ESLA news

The latest Smart Investors Daily articles mentioning ESLA.

ESLA research

Overview

Company profile and research snapshot.

Company profile

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
ESLA recent ratings
DateFirmRatingTarget
Feb 9, 2026D. Boral CapitalBuy—
Jan 28, 2026D. Boral CapitalBuy—
Nov 3, 2025D. Boral CapitalBuy—
Aug 12, 2025D. Boral CapitalBuy—
Jun 3, 2025D. Boral CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Oct 23, 2026

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday's regular session. The market value of their outstanding shares is at $7.9 million. Lucid Diagnostics (NASDAQ:LUCD)

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.